Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent Glioblastoma.
Chi AS, Cahill DP, Reardon DA, Wen PY, Mikkelsen T, Peereboom DM, Wong ET, Gerstner ER, Dietrich J, Plotkin SR, Norden AD, Lee EQ, Nayak L, Tanaka S, Wakimoto H, Lelic N, Koerner MV, Klofas LK, Bertalan MS, Arrillaga-Romany IC, Betensky RA, Curry WT, Borger DR, Balaj L, Kitchen RR, Chakrabortty SK, Valentino MD, Skog J, Breakefield XO, Iafrate AJ, Batchelor TT. Chi AS, et al. JCO Precis Oncol. 2020 Jun 8;4:PO.19.00295. doi: 10.1200/PO.19.00295. eCollection 2020. JCO Precis Oncol. 2020. PMID: 32923886 Free PMC article.
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.
Karschnia P, Arrillaga-Romany IC, Eichler A, Forst DA, Gerstner E, Jordan JT, Ly I, Plotkin SR, Wang N, Martinez-Lage M, Winter SF, Tonn JC, Rejeski K, von Baumgarten L, Cahill DP, Nahed BV, Shankar GM, Abramson JS, Barnes JA, El-Jawahri A, Hochberg EP, Johnson PC, Soumerai JD, Takvorian RW, Chen YB, Frigault MJ, Dietrich J. Karschnia P, et al. Neuro Oncol. 2023 Dec 8;25(12):2239-2249. doi: 10.1093/neuonc/noad118. Neuro Oncol. 2023. PMID: 37402650 Free PMC article.
Performance of a Hospital Pathway for Patients With a New Single Brain Mass.
Arrillaga-Romany I, Curry WT Jr, Jordan JT, Cahill DP, Nahed BV, Martuza RL, Loeffler JS, Järhult SJ, Muzikansky A, Cohen AB, Singhal AB, Goldstein JN, Batchelor TT. Arrillaga-Romany I, et al. J Oncol Pract. 2019 Mar;15(3):e211-e218. doi: 10.1200/JOP.17.00098. Epub 2019 Jan 25. J Oncol Pract. 2019. PMID: 30681891
Neurologic complications of cancer drug therapies.
Lee EQ, Arrillaga-Romany IC, Wen PY. Lee EQ, et al. Continuum (Minneap Minn). 2012 Apr;18(2):355-65. doi: 10.1212/01.CON.0000413663.42798.64. Continuum (Minneap Minn). 2012. PMID: 22810132 Review.
Current status of antiangiogenic therapies for glioblastomas.
Arrillaga-Romany I, Reardon DA, Wen PY. Arrillaga-Romany I, et al. Expert Opin Investig Drugs. 2014 Feb;23(2):199-210. doi: 10.1517/13543784.2014.856880. Epub 2013 Dec 10. Expert Opin Investig Drugs. 2014. PMID: 24320142 Review.
Antiangiogenic therapies for glioblastoma.
Arrillaga-Romany I, Norden AD. Arrillaga-Romany I, et al. CNS Oncol. 2014;3(5):349-58. doi: 10.2217/cns.14.31. CNS Oncol. 2014. PMID: 25363007 Free PMC article. Review.
49 results